Corvidia Therapeutics, Inc.
Overview
Corvidia Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for the treatment of cardiovascular and chronic kidney diseases. As a subsidiary of Novo Nordisk, it leverages cutting-edge technology to target inflammation and oxidative stress pathways.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Corvidia Therapeutics, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Corvidia Therapeutics, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.